about
The origin of the mammalian kidney: implications for recreating the kidney in vitroThe murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney developmentEssential roles of Sall1 in kidney developmentDirect transcriptional reprogramming of adult cells to embryonic nephron progenitors.Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis.A protocol for the identification and validation of novel genetic causes of kidney diseaseGeneration of kidney organoids from human pluripotent stem cellsRecreating kidney progenitors from pluripotent cells.Reprogramming somatic cells to a kidney fate.Generating a self-organizing kidney from pluripotent cells.A strategy for generating kidney organoids: Recapitulating the development in human pluripotent stem cells.Understanding kidney morphogenesis to guide renal tissue regeneration.Induction of intermediate mesoderm by retinoic acid receptor signaling from differentiating mouse embryonic stem cells.Human development, heredity and evolution.Identification of multipotent progenitors in the embryonic mouse kidney by a novel colony-forming assay.Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney.Identification of kidney mesenchymal genes by a combination of microarray analysis and Sall1-GFP knockin mice.Renal Subcapsular Transplantation of PSC-Derived Kidney Organoids Induces Neo-vasculogenesis and Significant Glomerular and Tubular Maturation In Vivo.Making a Kidney Organoid Using the Directed Differentiation of Human Pluripotent Stem Cells.Trb2, a mouse homolog of tribbles, is dispensable for kidney and mouse development.[Molecular structure associated with the development of the kidney]Evaluation of variability in human kidney organoidsMultivariate patterning of human pluripotent cells under perfusion reveals critical roles of induced paracrine factors in kidney organoid developmentDevelopment of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5
P50
Q28080749-746976A4-4705-4C2A-8A28-03FBC4DCE0FEQ28247514-54EB5ADC-D1E1-405D-B30B-C02C46F74602Q28276723-D4683CF6-DDF3-4F02-B8FD-2FC76B6962D8Q34350833-CA0626CA-E741-4FD3-BC5F-918B3DE5F66AQ34673674-CF60B1DD-5BE2-44CB-91F5-A86728528B95Q35776875-D24065C4-401C-402B-80FE-79ED3953CACBQ37420600-5120DDD1-3427-419E-B20C-F018C306994EQ38136556-D45856E7-643C-4B01-8966-1ABA7FB21EEFQ38248792-58FC4F80-2A1C-4B68-AA54-907D1C2029D6Q38412616-D54FF7E2-4DF3-4416-9EE9-7C10A310C824Q38827528-C71A8E22-B480-479D-A6CA-4EE26B8E3402Q38940497-74F86AE6-DAE2-4507-B9AF-FB0678B0FDA0Q39122591-6B89578B-BFE4-40FF-B9A8-7A45A3C0B4EDQ39386992-0F705517-4D9B-4353-A129-84225AB7E0B7Q42807539-7F0567CA-0DB2-43E3-89E3-679E3BE8AAFDQ45178758-AAE5EFAE-CC90-4E61-B4F9-05336BC68CE9Q47407715-7D5BF71E-9CE9-441E-87B6-6031F7C2978AQ50420951-DD018B7D-7A62-411A-AD36-992469811C9DQ50447773-55CE5166-6F1C-4B06-A880-BCBA3B86323FQ50629678-95AA4420-8CEF-450F-8A8E-43C536D9E5B2Q81349851-170A2905-C09E-459D-B200-4BD0CE68F02DQ90682055-AAD725B1-F83D-4C87-9557-F88F4757FD0AQ92622235-18CE9961-0A35-4600-A1C3-21B01E27580FQ96126804-5F58C22F-0EAA-4816-BE44-4F9C1BF5D81C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Minoru Takasato
@ast
Minoru Takasato
@en
Minoru Takasato
@es
Minoru Takasato
@nl
Minoru Takasato
@sl
type
label
Minoru Takasato
@ast
Minoru Takasato
@en
Minoru Takasato
@es
Minoru Takasato
@nl
Minoru Takasato
@sl
prefLabel
Minoru Takasato
@ast
Minoru Takasato
@en
Minoru Takasato
@es
Minoru Takasato
@nl
Minoru Takasato
@sl
P108
P106
P1153
8153551400
P31
P496
0000-0002-0458-7414